Recent Quarter Total Invested
$626.35 M
Recent Quarter Institutional Ownership Percentage
102.85%
Total Invested of Last Quarter
$634.95 M
Ownership Percentage of Last Quarter
100.93%
Olema Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 08/14/2024 | 9.14 M | $98.85 M | 0.00% | 16.23% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2024 | 7.90 M | $85.52 M | 0.00% | 14.04% |
| DEEP TRACK CAPITAL, LP | 08/14/2024 | 4.00 M | $43.28 M | 24.01% | 7.11% |
| BLACKROCK INC. | 08/13/2024 | 4.00 M | $43.27 M | 24.34% | 7.11% |
| POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 3.21 M | $34.75 M | 100.00% | 5.71% |
| LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 3.21 M | $34.72 M | -26.80% | 5.70% |
| VANGUARD GROUP INC | 08/13/2024 | 2.74 M | $29.68 M | 13.91% | 4.87% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 2.65 M | $28.73 M | 35.89% | 4.72% |
| STATE STREET CORP | 08/14/2024 | 1.95 M | $21.08 M | -38.71% | 3.46% |
| VIVO CAPITAL, LLC | 08/14/2024 | 1.87 M | $20.27 M | 0.00% | 3.33% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 1.68 M | $18.23 M | -12.98% | 2.99% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.06 M | $11.47 M | 26.30% | 1.88% |
| CANDRIAM S.C.A. | 08/05/2024 | 1.06 M | $11.45 M | 199.89% | 1.88% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2024 | 1.00 M | $10.82 M | 33.33% | 1.78% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 905,257 | $9.79 M | 8.33% | 1.61% |
| WOODLINE PARTNERS LP | 08/14/2024 | 852,554 | $9.22 M | 13.63% | 1.51% |
| GREAT POINT PARTNERS LLC | 08/14/2024 | 796,880 | $8.62 M | 100.00% | 1.42% |
| VICTORY CAPITAL MANAGEMENT INC | 08/05/2024 | 774,792 | $8.38 M | 26.88% | 1.38% |
| BOXER CAPITAL, LLC | 08/14/2024 | 650,000 | $7.03 M | 100.00% | 1.15% |
| MARSHALL WACE, LLP | 08/14/2024 | 588,996 | $6.37 M | 7.52% | 1.05% |
| GHOST TREE CAPITAL, LLC | 08/14/2024 | 550,000 | $5.95 M | 175.00% | 0.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/14/2024 | 546,863 | $5.92 M | 6.12% | 0.97% |
| AMERIPRISE FINANCIAL INC | 08/14/2024 | 441,066 | $4.77 M | 40.81% | 0.78% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 401,105 | $4.34 M | -8.22% | 0.71% |
| NORTHERN TRUST CORP | 08/14/2024 | 344,082 | $3.72 M | -1.45% | 0.61% |
| MORGAN STANLEY | 10/17/2024 | 335,571 | $3.63 M | -32.63% | 0.60% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 325,000 | $3.52 M | -29.35% | 0.58% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 275,000 | $2.98 M | 100.00% | 0.49% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 253,874 | $2.75 M | 1.95% | 0.45% |
| HIGHVISTA STRATEGIES LLC | 08/14/2024 | 247,880 | $2.68 M | 0.00% | 0.44% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 216,500 | $2.34 M | -67.10% | 0.38% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 208,583 | $2.26 M | 731.34% | 0.37% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 182,120 | $1.97 M | 90.08% | 0.32% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 08/12/2024 | 159,739 | $1.73 M | 100.00% | 0.28% |
| UBS GROUP AG | 08/14/2024 | 158,625 | $1.72 M | -8.39% | 0.28% |
| NEWTYN MANAGEMENT, LLC | 08/14/2024 | 140,000 | $1.51 M | -6.67% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 139,923 | $1.51 M | 72.10% | 0.25% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 133,395 | $1.44 M | -59.18% | 0.24% |
| CITADEL ADVISORS LLC | 08/14/2024 | 132,253 | $1.43 M | -83.06% | 0.24% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 129,500 | $1.40 M | -12.79% | 0.23% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 123,196 | $1.33 M | 41.67% | 0.22% |
| SECTORAL ASSET MANAGEMENT INC | 08/13/2024 | 118,480 | $1.28 M | -15.36% | 0.21% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 118,434 | $1.28 M | 17.39% | 0.21% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 116,926 | $1.27 M | -42.63% | 0.21% |
| TREXQUANT INVESTMENT LP | 08/13/2024 | 114,642 | $1.24 M | 100.00% | 0.20% |
| RAFFERTY ASSET MANAGEMENT, LLC | 08/13/2024 | 102,006 | $1.10 M | -65.39% | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 87,397 | $945,636 | 16.66% | 0.16% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 07/19/2024 | 87,312 | $944,716 | 100.00% | 0.16% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/14/2024 | 83,590 | $904,444 | 190.34% | 0.15% |
| DANA INVESTMENT ADVISORS, INC. | 08/27/2024 | 74,657 | $807,789 | 100.00% | 0.13% |
Olema Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of OLMA shares?
During the previous two years, 143 institutional investors and hedge funds held shares of Olema Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BVF INC/IL: 9.14 M
Paradigm Biocapital Advisors LP: 5.5 M
Deep Track Capital, LP: 4 M
BlackRock Funding, Inc. /DE: 3.85 M
Point72 Asset Management, L.P.: 3.69 M
Logos Global Management LP: 3.21 M
-
What percentage of Olema Pharmaceuticals, Inc. stock is owned by institutional investors?
102.85% of Olema Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at OLMA ?
Institutional investors have bought a total of 60.02 M shares in the last 24 months. This purchase volume represents approximately $471.75 M in transactions.